Mag. Christopher Wiese, BSc

Christopher Wiese started his PhD in October 2025 in the Cheminformatics Research Group, where he previously completed his Master's degree in Pharmacy. During his Master's thesis, he focused on pharmacophore modeling and molecular docking methods applied to the development of radiopharmaceuticals for tumor targeting. His current research focuses on benchmarking diverse virtual screening methodologies, including apo-pharmacophore approaches, molecular docking, and machine learning-based methods.

 

Room: 2E 354